Effects of Quinacrine on Expression of Hippo signaling Pathway Components (LATS1, LATS2, and YAP) in Human Breast Cancer Stem Cells
- PMID: 33247672
- PMCID: PMC8033116
- DOI: 10.31557/APJCP.2020.21.11.3171
Effects of Quinacrine on Expression of Hippo signaling Pathway Components (LATS1, LATS2, and YAP) in Human Breast Cancer Stem Cells
Abstract
Objective: The Hippo signaling pathway has important role in the pathogenesis of some tumors. Breast cancer is the most prevalent cancer among females in the world. In recent years, various articles referred to inhibiting effect of quinacrine, a derivative of 9-aminoacridine, on the growth of several types of cancer cells. In this study, we evaluated the effect of quinacrine on expression of LATS1, LATS2, and YAP genes of the Hippo signaling pathway and YAP level in human breast cancer stem cells (MDA-MB 231 cell line). This cell line of breast cancer expresses the triple negative characteristics.
Methods: MDA-MB 231 cells was treated with 0.5 µM of quinacrine for 3 days. The dose was selected using MTT assays. The expression of genes was quantified by Real-time PCR. The protein expression was performed by Western blotting. Significance of observations were checked by means of Mann-Whitney test using p.
Keywords: Cancer stem cells; Hippo signaling pathway; MDA-MB 231; quinacrine; triple negative breast cancer.
Figures



Similar articles
-
Sphingosylphosphorylcholine regulates the Hippo signaling pathway in a dual manner.Cell Signal. 2016 Dec;28(12):1894-1903. doi: 10.1016/j.cellsig.2016.09.004. Epub 2016 Sep 12. Cell Signal. 2016. PMID: 27634386
-
Decoding gene expression profiles of Hippo signaling pathway components in breast cancer.Mol Biol Rep. 2025 Feb 10;52(1):216. doi: 10.1007/s11033-025-10299-4. Mol Biol Rep. 2025. PMID: 39928181
-
An evolutionarily conserved negative feedback mechanism in the Hippo pathway reflects functional difference between LATS1 and LATS2.Oncotarget. 2016 Apr 26;7(17):24063-75. doi: 10.18632/oncotarget.8211. Oncotarget. 2016. PMID: 27006470 Free PMC article.
-
Hippo pathway in mammary gland development and breast cancer.Acta Biochim Biophys Sin (Shanghai). 2015 Jan;47(1):53-9. doi: 10.1093/abbs/gmu114. Epub 2014 Dec 2. Acta Biochim Biophys Sin (Shanghai). 2015. PMID: 25467757 Review.
-
The Role of Hippo Pathway in Cancer Stem Cell Biology.Mol Cells. 2018 Feb 28;41(2):83-92. doi: 10.14348/molcells.2018.2242. Epub 2018 Feb 5. Mol Cells. 2018. PMID: 29429151 Free PMC article. Review.
Cited by
-
Signaling pathways governing the maintenance of breast cancer stem cells and their therapeutic implications.Front Cell Dev Biol. 2023 Jul 10;11:1221175. doi: 10.3389/fcell.2023.1221175. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37492224 Free PMC article. Review.
-
Impact of MTHFD2 Expression in Bladder/Breast Cancer and Screening of Its Potential Inhibitor.ACS Omega. 2024 Oct 23;9(44):44193-44202. doi: 10.1021/acsomega.4c03599. eCollection 2024 Nov 5. ACS Omega. 2024. PMID: 39524662 Free PMC article.
-
Translational drugs targeting cancer stem cells in triple-negative breast cancer.Mol Ther Oncol. 2025 Jun 13;33(3):201008. doi: 10.1016/j.omton.2025.201008. eCollection 2025 Sep 18. Mol Ther Oncol. 2025. PMID: 40687439 Free PMC article. Review.
References
-
- Alipour S, Omranipour R, Jahanzad I, et al. Very young breast cancer in a referral center in Tehran, Iran: Review of 55 Cases Aged 25 or Less throughout 33 Years. Asian Pac J Cancer Prev. 2013;14:6529–32. - PubMed
-
- Cordenonsi M, Zanconato F, Azzolin L, et al. The Hippo transducer TAZ confers cancer stem cell-related traits on breast cancer cells. Cell. 2011;147:759–72. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous